Knockdown of NogoA prevents MPP+‑induced neurotoxicity in PC12 cells via the mTOR/STAT3 signaling pathway

Zhong,Jianbin; Li,Xie; Wan,Limei; Chen,Zhibang; Zhong,Simin; Xiao,Songhua; Yan,Zhengwen

doi:10.3892/mmr.2015.4637

Knockdown of NogoA prevents MPP+‑induced neurotoxicity in PC12 cells via the mTOR/STAT3 signaling pathway

Authors:
- Jianbin Zhong
- Xie Li
- Limei Wan
- Zhibang Chen
- Simin Zhong
- Songhua Xiao
- Zhengwen Yan
View Affiliations

Affiliations: Department of Neurology, Zeng Cheng People's Hospital and Boji Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 511300, P.R. China, Department of Neurology, Sun Yat‑sen Memorial Hospital of Sun Yat‑sen University, Guangzhou, Guangdong 511300, P.R. China
Published online on: December 4, 2015 https://doi.org/10.3892/mmr.2015.4637
Pages: 1427-1433

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

NogoA is a myelin‑associated protein, which is important in the inhibition of axonal fiber growth and in regeneration following injury of the mammalian central nervous system. A previous study suggested that NogoA may be key in the process of Parkinson's disease (PD), which is the second most common chronic neurodegenerative disorder worldwide. The regulatory mechanism underlying the effect of NogoA on the process of PD remains to be fully elucidated. The present study aimed to investigate the effect and underlying mechanism of NogoA on cellular viability, apoptosis and autophagy induced by 1‑methyl‑4‑phenylpyridinium (MPP+) in PC12 cells, a commonly used in vitro PD model. PC12 cells were treated with 1 mM MPP+ for 24 h and the cells were harvested for western blotting. The results demonstrated that the protien expression levels of NogoA were increased in the PC12 cells treated with MPP+. Subsequently, NogoA small interfering RNA was synthesized and transfected into PC12 cells to silence the expression of NogoA. NogoA knockdown significantly reduced the MPP+‑induced decrease in cell viability and apoptosis, detected using a cell counting kit‑8 and flow cytometric analysis, respectively. Interference in the expression of NogoA increased the MPP+‑induced decrease in mitochondrial membrane potential, determined quantitatively by flow cytometry using JC-1 dye, and the protein levels of Beclin‑1. In addition, MPP+ treatment activated the mammalian target of rapamycin (mTOR)/signal transducer and activator of transcription 3 (STAT3) signaling pathway. Knockdown of NogoA significantly inhibited the expression levels of mTOR and STAT3. Furthermore, overexpression of NogoA had similar neurotoxic effects on the PC12 cells as MPP+ treatment. Treatment with rapamycin, an inhibitor of the mTOR/STAT3 signaling pathway had a similar effect to that of NogoA knockdown in the MPP+‑treated PC12 cells. Taken together, the results from the present study demonstrated that NogoA may regulate MPP+‑induced neurotoxicity in PC12 cells via the mTOR/STAT3 signaling pathway and provided an explanation regarding the regulatory mechanism of NogoA on the process of PD.

View Figures

View References

1	de Lau LM, Koudstaal PJ, Hofman A and Breteler MM: Subjective complaints precede Parkinson disease: The rotterdam study. Arch Neurol. 63:362–365. 2006. View Article : Google Scholar : PubMed/NCBI
2	Schapira AH and Olanow CW: Neuroprotection in Parkinson disease: Mysteries, myths, and misconceptions. JAMA. 291:358–364. 2004. View Article : Google Scholar : PubMed/NCBI
3	Hirsch E, Graybiel AM and Agid YA: Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature. 334:345–348. 1988. View Article : Google Scholar : PubMed/NCBI
4	Jellinger KA: The pathology of Parkinson's disease. Adv Neurol. 86:55–72. 2001.PubMed/NCBI
5	Braak H, Del Tredici K, Rüb U, de Vos RA, Jansen Steur EN and Braak E: Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 24:197–211. 2003. View Article : Google Scholar
6	Fahn S and Sulzer D: Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx. 1:139–154. 2004. View Article : Google Scholar
7	Braak H, Ghebremedhin E, Rüb U, Bratzke H and Del Tredici K: Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 318:121–134. 2004. View Article : Google Scholar : PubMed/NCBI
8	Chaudhuri KR and Odin P: The challenge of non-motor symptoms in Parkinson's disease. Prog Brain Res. 184:325–341. 2010. View Article : Google Scholar : PubMed/NCBI
9	Hou RR, Chen JZ, Chen H, Kang XG, Li MG and Wang BR: Neuroprotective effects of (−)-epigallocatechin-3-gallate (EGCG) on paraquat-induced apoptosis in PC12 cells. Cell Biol Int. 32:22–30. 2008. View Article : Google Scholar
10	Schwab ME: Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci. 11:799–811. 2010. View Article : Google Scholar : PubMed/NCBI
11	Zagrebelsky M, Schweigreiter R, Bandtlow CE, Schwab ME and Korte M: Nogo-A stabilizes the architecture of hippocampal neurons. J Neurosci. 30:13220–13234. 2010. View Article : Google Scholar : PubMed/NCBI
12	Kempf A and Schwab ME: Nogo-A represses anatomical and synaptic plasticity in the central nervous system. Physiology (Bethesda). 28:151–163. 2013. View Article : Google Scholar
13	Mironova YA and Giger RJ: Where no synapses go: Gatekeepers of circuit remodeling and synaptic strength. Trends Neurosci. 36:363–373. 2013. View Article : Google Scholar : PubMed/NCBI
14	Jitoku D, Hattori E, Iwayama Y, Yamada K, Toyota T, Kikuchi M, Maekawa M, Nishikawa T and Yoshikawa T: Association study of Nogo-related genes with schizophrenia in a Japanese case-control sample. Am J Med Genet B Neuropsychiatr Genet. 156B:581–592. 2011. View Article : Google Scholar : PubMed/NCBI
15	Krištofiková Z, Vrajová M, Sirová J, Valeš K, Petrásek T, Schönig K, Tews B, Schwab M, Bartsch D, Stuchlík A and Rípová D: N-Methyl-d-Aspartate receptor - Nitric oxide synthase pathway in the cortex of Nogo-A-Deficient rats in relation to brain laterality and schizophrenia. Front Behav Neurosci. 7:902013. View Article : Google Scholar
16	Delekate A, Zagrebelsky M, Kramer S, Schwab ME and Korte M: NogoA restricts synaptic plasticity in the adult hippocampus on a fast time scale. Proc Natl Acad Sci USA. 108:2569–2574. 2011. View Article : Google Scholar : PubMed/NCBI
17	Zemmar A, Weinmann O, Kellner Y, Yu X, Vicente R, Gullo M, Kasper H, Lussi K, Ristic Z, Luft AR, et al: Neutralization of Nogo-A enhances synaptic plasticity in the rodent motor cortex and improves motor learning in vivo. J Neurosci. 34:8685–8698. 2014. View Article : Google Scholar : PubMed/NCBI
18	Wälchli T, Pernet V, Weinmann O, Shiu JY, Guzik-Kornacka A, Decrey G, Yüksel D, Schneider H, Vogel J, Ingber DE, et al: Nogo-A is a negative regulator of CNS angiogenesis. Proc Natl Acad Sci USA. 110:E1943–E1952. 2013. View Article : Google Scholar : PubMed/NCBI
19	Willi R, Weinmann O, Winter C, Klein J, Sohr R, Schnell L, Yee BK, Feldon J and Schwab ME: Constitutive genetic deletion of the growth regulator Nogo-A induces schizophrenia-related endophenotypes. J Neurosci. 30:556–567. 2010. View Article : Google Scholar : PubMed/NCBI
20	Tews B, Schönig K, Arzt ME, Clementi S, Rioult-Pedotti MS, Zemmar A, Berger SM, Schneider M, Enkel T, Weinmann O, et al: Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function. Proc Natl Acad Sci USA. 110:6583–6588. 2013. View Article : Google Scholar : PubMed/NCBI
21	GrandPré T, Li S and Strittmatter SM: Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature. 417:547–551. 2002. View Article : Google Scholar : PubMed/NCBI
22	Wang H, Shen J, Xiong N, Zhao H and Chen Y: Protein kinase B is involved in Nogo-66 inhibiting neurite outgrowth in PC12 cells. Neuroreport. 22:733–738. 2011. View Article : Google Scholar : PubMed/NCBI
23	Yan J, Zhou X, Guo JJ, Mao L, Wang YJ, Sun J, Sun LX, Zhang LY, Zhou XF and Liao H: Nogo-66 inhibits adhesion and migration of microglia via GTPase Rho pathway in vitro. J Neurochem. 120:721–731. 2012. View Article : Google Scholar
24	Cossarizza A, Baccarani-Contri M, Kalashnikova G and Franceschi C: A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethyl-benzimidazolcarbocyanine iodide (JC-1). Biochem Biophys Res Commun. 197:40–45. 1993. View Article : Google Scholar : PubMed/NCBI
25	Akbik F, Cafferty WB and Strittmatter SM: Myelin associated inhibitors: A link between injury-induced and experience-dependent plasticity. Exp Neurol. 235:43–52. 2012. View Article : Google Scholar
26	Pernet V and Schwab ME: The role of Nogo-A in axonal plasticity, regrowth and repair. Cell Tissue Res. 349:97–104. 2012. View Article : Google Scholar : PubMed/NCBI
27	Rolando C, Parolisi R, Boda E, Schwab ME, Rossi F and Buffo A: Distinct roles of Nogo-a and Nogo receptor 1 in the homeostatic regulation of adult neural stem cell function and neuroblast migration. J Neurosci. 32:17788–17799. 2012. View Article : Google Scholar : PubMed/NCBI
28	Willi R and Schwab ME: Nogo and Nogo receptor: Relevance to schizophrenia? Neurobiol Dis. 54:150–157. 2013. View Article : Google Scholar : PubMed/NCBI
29	Deng Q and Yang X: Protective effects of Gynostemma pentaphyllum polysaccharides on PC12 cells impaired by MPP(+). Int J Biol Macromol. 69:171–175. 2014. View Article : Google Scholar : PubMed/NCBI
30	Cheng B, Guo Y, Li C, Ji B, Pan Y, Chen J and Bai B: Edaravone protected PC12 cells against MPP(+)-cytoxicity via inhibiting oxidative stress and up-regulating heme oxygenase-1 expression. J Neurol Sci. 343:115–119. 2014. View Article : Google Scholar : PubMed/NCBI
31	Swiech L, Perycz M, Malik A and Jaworski J: Role of mTOR in physiology and pathology of the nervous system. Biochim Biophys Acta. 1784:116–132. 2008. View Article : Google Scholar
32	Jiang LB, Cao L, Yin XF, Yasen M, Yishake M, Dong J and Li XL: Activation of autophagy via Ca⁽²⁺⁾ dependent AMPK/mTOR pathway in rat notochordal cells is a cellular adaptation under hyperosmotic stress. Cell Cycle. 14:867–879. 2015. View Article : Google Scholar
33	Kumar S, Guru SK, Pathania AS, Manda S, Kumar A, Bharate SB, Vishwakarma RA, Malik F and Bhushan S: Fascaplysin induces caspase mediated crosstalk between apoptosis and autophagy through the inhibition of PI3K/AKT/mTOR signaling cascade in human leukemia HL-60 cells. J Cell Biochem. 116:985–997. 2015. View Article : Google Scholar : PubMed/NCBI
34	Mukhopadhyay S, Panda PK, Sinha N, Das DN and Bhutia SK: Autophagy and apoptosis: Where do they meet? Apoptosis. 19:555–566. 2014. View Article : Google Scholar : PubMed/NCBI